INPLASY202450109

Comprehensive Evaluation of PD-1 and PD-L1 Inhibitors for Pancreatic Ductal Adenocarcinoma: A Protocol of a Systematic Review and Meta-analysis

Keywords: Pancreatic ductal adenocarcinoma, immune checkpoint inhibitor, PD-1, PD-L1, cancer, oncology, prognosis.

Review Status: completed but not published